Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China

Next Previous
Trial Profile

Phase 1 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 19 Oct 2016 Status changed from not yet recruiting to recruiting, according to Sinovac Biotech media release.
  • 23 Aug 2016 Planned initiation date changed from 1 Jan 2016 to 1 Sep 2016, as reported in a Sinovac Biotech media release.
  • 10 Dec 2015 According to a Sinovac media release, the China Food and Drug Administration (CFDA) has given approval to start human clinical trials on Sabin Inactivated Polio Vaccine in China. The Company plans to start the clinical trial in the first half of 2016 and expects to complete these trials by 2018.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top